Skip to content
Dalibor Rohac /

How the EU Has Bungled Its Vaccine Rollout

It's a combination of a lengthy approval process, the choice to rely on a 'diversified portfolio' of vaccines, and a concession to a French vaccine that isn't ready.
How the EU Has Bungled Its Vaccine Rollout

In theory, leaving vaccine procurement to the EU made perfect sense for member nations. The bloc was surely going to have a stronger negotiating position than any individual European country. Coordination would ensure that no European country would be left behind with insufficient supplies. “We also agree that speed is of the essence in this case,” health ministers of France, Germany, Italy, and the Netherlands wrote to the European Commission in June, “so we deem it very useful if the commission takes the lead in this process.”

Want to see more of The Dispatch in Google search?

Add Us as a Preferred Source

Dalibor Rohac is a senior fellow at the American Enterprise Institute.

More We Think You’d Like

Loading